http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011012113-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_424db9d56b06a23aed410fcf5df652f3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F32-08
filingDate 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab146ec69c7efff86fcf711c46566758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_221b33e48037821dc2914a7714d83926
publicationDate 2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2011012113-A
titleOfInvention Asymmetric membrane of siloxane functional cyclic olefin (co) polymer and process for producing the same
abstract The present invention provides an asymmetric membrane having excellent pore characteristics, having nano-micron level micropores on the surface, and excellent flexibility and heat resistance. An asymmetric membrane comprising a cyclic olefin polymer obtained by addition polymerization of a monomer composition containing a siloxane functional cyclic olefin represented by the formula (1). (In the formula, R 1 is independently an alkyl group having 1 to 12 carbon atoms and / or an aryl group having 6 to 10 carbon atoms, X is a predetermined siloxy group, and a is an integer of 1 to 3) And b is an integer of 0 to 2.) [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385210-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10287400-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013091759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011084681-A
priorityDate 2009-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011510805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02222715-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007070337-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008018363-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010174099-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450128398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458433298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415770537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149252422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415893423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414009156
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154083196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426099066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431859077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159046975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458434036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420680123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456370357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123559948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431906686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID236409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415768216

Total number of triples: 49.